Insempra, an innovative biotechnology company at the forefront of sustainable ingredient development, has announced the successful completion of a $20 million Series A financing round. This significant investment, following an initial $15 million seed round in 2021, marks a crucial step in accelerating Insempra's pioneering efforts to revolutionize the beauty and food industries with its market-first approach.
By harnessing the power of advanced technologies, the company aims to address pressing environmental concerns while meeting consumers' evolving demands and regulatory standards.
The Series A round saw participation from a mix of existing and new investors, underscoring the widespread recognition of Insempra's potential to reshape industrial manufacturing. Notable contributors include EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten, Acequia Capital, as well as the corporate venture of global FMCG leader Henkel, Henkel dx Ventures, Bayern Kapital, and Alante Capital.
Jens Klein, the visionary founder and CEO of Insempra, brings a wealth of experience to the table, having previously spearheaded groundbreaking initiatives in the realm of biologically superior ingredients. Klein's track record, exemplified by his role as former CEO of AMSilk GmbH, a pioneering supplier of vegan silk polymers, underscores his leadership in driving transformative change within the industry.
“We are grateful for the support of this group of investors who have recognized the potential of Insempra’s market-first approach and innovative technology platforms. Working in collaboration with nature, we will continue to expand our capacity to develop intrinsically sustainable materials that are superior in quality and will reduce our dependency on chemical industrialization processes,” said Jens Klein, founder and CEO of Insempra.
Ted Persson, Partner at EQT Ventures, added: “Insempra has both the team and the technology to drive a revolution in industrial manufacturing and gain rapid market traction for its products. New technology platforms such as Insempra’s have the potential to dramatically change the manufacturing processes of multiple multibillion-dollar industries, developing customized ingredients to fit market needs.”
Insempra's mission to usher in a new era of sustainable ingredient innovation aligns with the growing imperative for businesses to embrace environmentally responsible practices. With its advanced technology platform, the company stands ready to empower leading brands across beauty, food, and fashion to embark on a transformative journey towards a more sustainable future.
Insempra, an innovative biotechnology company at the forefront of sustainable ingredient development, has announced the successful completion of a $20 million Series A financing round. This significant investment, following an initial $15 million seed round in 2021, marks a crucial step in accelerating Insempra's pioneering efforts to revolutionize the beauty and food industries with its market-first approach.
By harnessing the power of advanced technologies, the company aims to address pressing environmental concerns while meeting consumers' evolving demands and regulatory standards.
The Series A round saw participation from a mix of existing and new investors, underscoring the widespread recognition of Insempra's potential to reshape industrial manufacturing. Notable contributors include EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten, Acequia Capital, as well as the corporate venture of global FMCG leader Henkel, Henkel dx Ventures, Bayern Kapital, and Alante Capital.
Jens Klein, the visionary founder and CEO of Insempra, brings a wealth of experience to the table, having previously spearheaded groundbreaking initiatives in the realm of biologically superior ingredients. Klein's track record, exemplified by his role as former CEO of AMSilk GmbH, a pioneering supplier of vegan silk polymers, underscores his leadership in driving transformative change within the industry.
“We are grateful for the support of this group of investors who have recognized the potential of Insempra’s market-first approach and innovative technology platforms. Working in collaboration with nature, we will continue to expand our capacity to develop intrinsically sustainable materials that are superior in quality and will reduce our dependency on chemical industrialization processes,” said Jens Klein, founder and CEO of Insempra.
Ted Persson, Partner at EQT Ventures, added: “Insempra has both the team and the technology to drive a revolution in industrial manufacturing and gain rapid market traction for its products. New technology platforms such as Insempra’s have the potential to dramatically change the manufacturing processes of multiple multibillion-dollar industries, developing customized ingredients to fit market needs.”
Insempra's mission to usher in a new era of sustainable ingredient innovation aligns with the growing imperative for businesses to embrace environmentally responsible practices. With its advanced technology platform, the company stands ready to empower leading brands across beauty, food, and fashion to embark on a transformative journey towards a more sustainable future.